EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

In vitro quality of whole blood‐derived red cell concentrates collected, processed and stored in a blood bag set plasticized with di (2‐ethylhexyl) terephthalate

Tatiana Stephenson, Anita Howell, Carly Olafson, Chryslain Sumian, Stefan Reichenberg, Quentin Brebant, Ken McTaggart, Geraldine M Walsh iD

Vox Sanguinis · 2025

DOI: 10.1111/vox.70087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2025. Verfasst von Tatiana Stephenson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Product and Process Development, Canadian Blood Services, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Erythrocytes, Blood Preservation, Diethylhexyl Phthalate, Plasticizers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Due to toxicity concerns, di(2‐ethylhexyl) phthalate (DEHP)—the most used plasticizer in polyvinyl chloride (PVC) whole blood (WB) collection and processing bag sets—will be effectively prohibited in medical devices in Europe from 2030. Removal of DEHP will primarily impact the in vitro quality of red blood cell (RBC) concentrates (RCCs) and DEHP‐free sets with alternate additive solutions (ASs) that better preserve RBCs in the absence of DEHP are being developed. This study compared the in vitro quality of RCCs from di (2‐ethylhexyl) terephthalate (DEHT)/phosphate‐adenine‐glucose‐guanosine‐saline‐mannitol (PAGGSM) and DEHP/saline‐adenine‐glucose‐mannitol (SAGM) sets. Materials and Methods WB was collected into citrate‐phosphate‐dextrose (CPD) in either 500‐mL DEHP/SAGM ( n = 37) or prototype 475‐mL DEHT/PAGGSM bag sets ( n = 29). Leucoreduced (LR)‐RCCs were produced using semi‐automated top/bottom processing within 24 h of collection. RBC quality, including haemolysis, supernatant metabolic parameters and RBC deformability, was measured on D43 (1‐day after expiry). Results All RCCs in the study had haemolysis

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErythrocytesBlood PreservationDiethylhexyl PhthalatePlasticizersHumansHemolysis

Stichwörter der Autor:innen

DEHPDEHTRCCadditive solutionsin vitroquality

Substanzen

Diethylhexyl PhthalatePlasticizers

Autor:innen und Institutionen

  • Product and Process Development, Canadian Blood Services, Vancouver, British Columbia, Canada.
  • Product and Process Development, Canadian Blood Services, Edmonton, Alberta, Canada.
  • Clinical Regulatory Affairs, Macopharma, Mouvaux, France.
  • Research and Development, Macopharma, Mouvaux, France.
  • Product and Process Development, Canadian Blood Services, Ottawa, Ontario, Canada.

ORCID-Profile: Geraldine M Walsh

Zitieren

APA

Stephenson, T., Howell, A., Olafson, C., Sumian, C., Reichenberg, S., Brebant, Q., McTaggart, K., & Walsh, G. M. (2025). In vitro quality of whole blood‐derived red cell concentrates collected, processed and stored in a blood bag set plasticized with di (2‐ethylhexyl) terephthalate. Vox Sanguinis. https://doi.org/10.1111/vox.70087

Vancouver

Stephenson T, Howell A, Olafson C, Sumian C, Reichenberg S, Brebant Q, et al. In vitro quality of whole blood‐derived red cell concentrates collected, processed and stored in a blood bag set plasticized with di (2‐ethylhexyl) terephthalate. Vox Sanguinis. 2025. doi:10.1111/vox.70087

BibTeX
@article{Stephenson2025,
  author = {Stephenson, Tatiana and Howell, Anita and Olafson, Carly and Sumian, Chryslain and Reichenberg, Stefan and Brebant, Quentin and McTaggart, Ken and Walsh, Geraldine M},
  title = {In vitro quality of whole blood‐derived red cell concentrates collected, processed and stored in a blood bag set plasticized with di (2‐ethylhexyl) terephthalate},
  journal = {Vox Sanguinis},
  year = {2025},
  doi = {10.1111/vox.70087}
}
Kostenlos starten →